The BDB seeks a contractor to provide non-personal Research and Development services for a collaborative study with the University of Notre Dame. The study will test innovative antibacterial nanoparticles against combat-relevant, multi-drug resistant *Pseudomonas aeruginosa*. The goal is to contribute to FDA approval of this therapy to benefit military and civilian health. The contractor must supply qualified personnel, appropriate laboratory facilities, and all necessary research materials. No specific budget, performance location, or non-bid timelines are detailed in the provided description.